|  |



Biopharma Targets an HIV Cure as NIH Funding Cuts Threaten To Derail Progress

... antiretroviral therapy (ART) controlled the virus in people with HIV and, more recently, pre-exposure prophylaxis (PrEP) allowed high-risk ...


View article...


Top stories of the last 30 days